Greater reduction seen in mortality with bariatric surgery than GLP-1 RAs

Bariatric metabolic surgery (BMS) is associated with a greater reduction in mortality than glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment among adults with a diabetes duration of 10 years or less, according to a study published online June 7 in JAMA Network Open. Dror Dicker, M.D., from Rabin Medical Center in Petah Tikva, Israel, and colleagues compared all-cause mortality and nonfatal major adverse cardiovascular events associated with BMS versus GLP-1 RAs for adults with obesity and diabetes and without known cardiovascular disease in an observational retrospective cohort study. Data were Read More

Related posts:

  1. Intake reduction and pre-surgery body weight explain efficacy of weight loss surgery, study shows
  2. HMN: Can you take Wegovy after bariatric surgery in 2025?
  3. Study demonstrates sustained reduction in child mortality following educational interventions in low-resourced countries
  4. Metabolic and bariatric surgery found to prevent pre-diabetes from developing into type 2 diabetes in most patients
  5. Women over 65 face higher mortality rates at low quality hospitals after heart surgery
  6. Study shows stricter alcohol policies are associated with reduction in homicides
  7. How many days does it take for mosquitoes in Greater Paris to transmit arboviruses?
  8. Athletes and public could benefit from new research on reduction of upper respiratory tract illness

Leave a Reply

Your email address will not be published. Required fields are marked *